Relvar Ellipta

Licence status
Authorised: 13/11/2013
Active substances
Fluticasone furoate, Vilanterol trifenatate micronised
Dosage Form
Inhalation powder, pre-dispensed
Licence number
EU/1/13/886/004-006
Licence holder
GlaxoSmithKline (Ireland) Limited

Product documents

Licence information

ATC code
R03AK10 vilanterol and fluticasone furoate
Route of supply
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
13/11/2013

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie